Related Experiment Video
Updated: Jul 6, 2025
10:38
Induction of Experimental Autoimmune Hypophysitis in SJL Mice
Published on: December 17, 2010
11.5K
Idiopathic Hypertrophic Spinal Pachymeningitis.
Ashutosh Gupta1, Daniel Um1, Rohan Samant2
1McGovern Medical School, UT Health Science Center at Houston, Houston, TX 77030, USA.
Journal of Medical Cases
|January 8, 2024
Summary
Idiopathic hypertrophic spinal pachymeningitis (IHSP) is a rare condition. This case study shows a 40-year-old male with IHSP achieved full recovery with steroids alone, highlighting a potential alternative to surgery.
Area of Science:
- Neurology
- Pathology
Background:
- Hypertrophic pachymeningitis (HP) involves rare dural thickening and fibrosis, potentially causing compressive neurological deficits.
- Spinal HP often necessitates surgical intervention for effective management.
Observation:
- A 40-year-old male presented with bilateral upper limb weakness and cervical cord compression due to diffuse spinal dural thickening on MRI.
- Despite extensive workup, the patient was diagnosed with idiopathic hypertrophic spinal pachymeningitis (IHSP).
Findings:
- The patient experienced complete symptom resolution and showed no relapse after two years of high-dose steroid treatment.
- Analysis of IHSP cases indicates a typical onset after age 50, predominantly in females, with weakness and sensory loss as common symptoms.
- Cerebrospinal fluid (CSF) and inflammatory markers (ESR, CRP) aid in assessing disease progression and prognosis.
Implications:
- This case suggests that steroids alone may be a viable treatment for IHSP, particularly in patients without severe myelopathic signs.
- Steroid monotherapy offers a less invasive alternative to surgery for selected IHSP patients.
- Further research into steroid responsiveness in IHSP is warranted to refine treatment guidelines.
